Table 1 Timing of clinical trials and FDA approval for selected targeted therapies
1
Table 1 Timing of clinical trials and FDA approval for selected targeted therapies Maxwell, K. N. & Domchek, S. M. (2012) Cancer treatment according to BRCA1 and BRCA2 mutations Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2012.123
-
Upload
jerry-mays -
Category
Documents
-
view
18 -
download
3
description
Table 1 Timing of clinical trials and FDA approval for selected targeted therapies. Maxwell, K. N. & Domchek, S. M. ( 2012) Cancer treatment according to BRCA1 and BRCA2 mutations Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2012.123. - PowerPoint PPT Presentation
Transcript of Table 1 Timing of clinical trials and FDA approval for selected targeted therapies
Table 1 Timing of clinical trials and FDA approval for selected targeted therapies
Maxwell, K. N. & Domchek, S. M. (2012) Cancer treatment according to BRCA1 and BRCA2 mutationsNat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2012.123
